- European equities rally for 5th week
- NFP report beat expectations
- Pfizer (PFE.US) stock soar on positive test results for COVID-19 pill
- Gold highest since early September
European indices finished today's session mostly higher, led by advances in travel stocks after a positive update from US drugmaker Pfizer on its pill for Covid-19, amid persistent optimism about earnings season and the latest policy decisions by major central banks. ECB President Lagarde has assured the markets that the bloc's central bank was not predicting a rate hike in 2022. On a weekly basis, European markets secured their fifth straight week of gains, the longest winning streak since April.
Meanwhile, three main Wall Street averages jumped to fresh record highs as investors digested a stronger-than-expected US jobs report, alongside a batch of corporate results. Data showed the US economy added 531 thousand jobs in October, while the unemployment fell to a new pandemic low. However, the NFP report was not the only optimistic news. A major development in the fight against the pandemic boosted shares of Pfizer (PFE.US), which rose more than 11% premarket after the company said its Covid-19 drug, used with an HIV drug, cut the risk of hospitalization by 89%. However later in the session indices gave away part of the early gains.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appWTI crude futures rose more than 3% to above $81 a barrel on Friday, while Brent added nearly 2.0% and is trading around $82.70 as OPEC+ producers rebuffed a US call to increase output. On Thursday, OPEC+ agreed to stick to the plan of raising oil output by 400,000 barrels per day from December despite pressure from the Biden administration to pump more oil. Still, oil is heading for an over 3% weekly loss. Elsewhere, gold jumped 1.3%, while silver is trading 1.6% higher as demand for non-yielding assets such as precious metals returned, after big central banks showed divergences with market hawks on interest rate and tapering outlooks.
Gold extended yesterday's upward move and is on course for a weekly gain after a succession of central banks this week defied expectations of a hawkish pivot. Price broke above psychological resistance at $1800 which is strengthened by downward trendline. Next target for bulls is located at $1826.53 and is marked with 38.2% Fibonacci retracement and previous price reactions. Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
